| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/11/2000 | CA2162001C Salicylic acid derivative used for the stabilization of an oil-in-water emulsion |
| 01/11/2000 | CA2150832C Antibiotic formulation and use for bacterial infections |
| 01/11/2000 | CA2089519C N-acetylcarboxymethylchitosan derivatives and process for preparation thereof |
| 01/11/2000 | CA2065311C Solid matrix system for transdermal drug delivery |
| 01/06/2000 | WO2000000507A1 Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon |
| 01/06/2000 | WO2000000224A2 Method for transporting a molecular substance in predetermined areas of eucaryotic cells |
| 01/06/2000 | WO2000000222A1 Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents |
| 01/06/2000 | WO2000000221A1 Water soluble dry compositions |
| 01/06/2000 | WO2000000220A1 Pharmaceutical composition containing an ester or amide pla2 inhibitor |
| 01/06/2000 | WO2000000181A1 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| 01/06/2000 | WO2000000177A1 Calcium phosphate coated vesicles |
| 01/06/2000 | WO2000000157A2 Use of tempo and tempo derivatives for inducing cell death |
| 01/06/2000 | WO2000000156A2 Methods for modulating immunological responses by targeting antigen to apcs in conjuction with anti-cd40 ligands |
| 01/06/2000 | WO2000000120A1 Methods and transdermal compositions for pain relief |
| 01/06/2000 | WO2000000033A1 Macromolecule-lipid complexes and methods for making and using |
| 01/06/2000 | WO1999058656A3 Sustained dna delivery from structural matrices |
| 01/06/2000 | WO1999056776A3 Adjuvant composition and methods for its use |
| 01/06/2000 | WO1999056723A3 Hemoglobine-haptoglobin complexes for targeted drug delivery |
| 01/06/2000 | WO1999044629A3 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 01/06/2000 | CA2335986A1 Use of tempo and tempo derivatives for inducing cell death |
| 01/06/2000 | CA2335852A1 Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents |
| 01/06/2000 | CA2335837A1 Methods and transdermal compositions for pain relief |
| 01/06/2000 | CA2331388A1 Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon |
| 01/06/2000 | CA2311119A1 Method for transporting a molecular substance in predetermined areas of eucaryotic cells |
| 01/05/2000 | EP0968726A1 Process for adding pharmaceutically active compounds to substrates |
| 01/05/2000 | EP0968713A1 Plasters containing isosorbide nitrate |
| 01/05/2000 | EP0968298A2 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
| 01/05/2000 | EP0968291A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 01/05/2000 | EP0968233A1 Improvements relating to bran gels |
| 01/05/2000 | EP0968228A1 Calcium phosphopeptide complexes |
| 01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 01/05/2000 | EP0967999A2 Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents |
| 01/05/2000 | EP0967998A2 Polymeric carrier |
| 01/05/2000 | EP0967995A1 Composition comprising immunoglobulin |
| 01/05/2000 | EP0967993A2 Anti-cocaine vaccine |
| 01/05/2000 | EP0967975A1 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 01/05/2000 | EP0967967A1 Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin |
| 01/05/2000 | EP0954291A4 Soluble form osmotic dose delivery system |
| 01/05/2000 | EP0760683B1 Bile acid conjugates, derivatives thereof with metal complexes and related uses |
| 01/05/2000 | EP0652758B1 Diphtheria toxin vaccines |
| 01/05/2000 | EP0610445B1 Use of compositions comprising a bactericidal/permeability increasing protein and a lipid carrier |
| 01/05/2000 | EP0572502B1 Polyamino acid dispersants |
| 01/05/2000 | DE19829713C1 Therapeutisches System mit Zusatz von Perglanzpigmenten Therapeutic system with the addition of pearlescent pigments |
| 01/05/2000 | DE19821625C1 Pharmazeutische Zubereitung Pharmaceutical composition |
| 01/05/2000 | CN1240479A Truncated soluble tumor necrosis factor type-I and type-II receptors |
| 01/05/2000 | CN1240461A Polymer film composition for capsules |
| 01/05/2000 | CN1240364A Platelet substitutes and conjugation methods suitable for their preparation |
| 01/05/2000 | CN1240363A Pharmaceutical composition for oral administration |
| 01/05/2000 | CN1240362A Pharmaceutical compositions for freeze drying |
| 01/05/2000 | CN1240361A Use of low molecular weight amino alcohols in ophthalmic compositions |
| 01/05/2000 | CN1240353A Local anesthetic for external use |
| 01/05/2000 | CN1240347A New aqueous medicament preparations for the production of propellent gas-free aerosols |
| 01/05/2000 | CN1240346A Injectable depot gel composition and method of preparing the composition |
| 01/05/2000 | CN1240132A Controlled release formulation |
| 01/04/2000 | US6011062 Polyethoxylated castor oil |
| 01/04/2000 | US6011022 Topical application of muscarinic analgesic drugs such as neostigmine |
| 01/04/2000 | US6011018 Regulated transcription of targeted genes and other biological events |
| 01/04/2000 | US6011011 Suspensions of somatotropin and growth hormone releasing factor in low molecular weight polyethylene glycol. |
| 01/04/2000 | US6011008 Producing a water-soluble polysaccharide conjugate of an oxidation-sensitive substance |
| 01/04/2000 | US6011002 Circularly permuted ligands and circularly permuted chimeric molecules |
| 01/04/2000 | US6010999 Stabilization of fibroblast growth factors by modification of cysteine residues |
| 01/04/2000 | US6010718 Extended release formulations of erythromycin derivatives |
| 01/04/2000 | US6010717 Water solubility; powder |
| 01/04/2000 | US6010716 Containing fatty or alcohol absorption promoter |
| 01/04/2000 | US6010691 Methods for enhancing permeation of a topically administered physiologically active substance |
| 01/04/2000 | US6010681 Biodegradable blood-pool contrast agents |
| 01/04/2000 | CA2161774C Synthetic viscoelastic material for ophthalmic applications |
| 01/04/2000 | CA2045472C Drug delivery compositions |
| 01/04/2000 | CA2029368C Injectable solution and process for preparing same |
| 01/04/2000 | CA2025790C New lipidic compositions derivated from spingosins, process for their preparation and uses, especially as cosmetics and dermatologic agents |
| 12/30/1999 | DE19854497A1 Stable, flowable water-in-oil emulsions with high water content, useful as bases in cosmetic or dermatological formulations |
| 12/30/1999 | DE19829005A1 A method to transport molecular substances inside eukaryotic cell |
| 12/30/1999 | DE19828463A1 4,4-Diarylbutadiene als wasserlösliche photostabile UV-Filter für kosmetische und pharmazeutische Zubereitungen 4,4-diarylbutadienes as water-soluble photostable UV filters for cosmetic and pharmaceutical preparations |
| 12/30/1999 | DE19828273A1 Transdermal patch useful for controlled release of estradiol and norethisterone acetate |
| 12/29/1999 | WO1999067370A1 A polypeptide-polymer conjugate |
| 12/29/1999 | WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 12/29/1999 | WO1999067296A1 Polymers for delivering nitric oxide in vivo |
| 12/29/1999 | WO1999067291A2 Site specific protein modification by mutagenesis |
| 12/29/1999 | WO1999067284A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 12/29/1999 | WO1999067017A1 Liquid thickener for surfactant systems |
| 12/29/1999 | WO1999066959A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 12/29/1999 | WO1999066951A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | WO1999066943A1 Dietary supplement for supporting cerebrovascular tone |
| 12/29/1999 | WO1999066942A1 Compounds obtained from salvia species having antiviral activity |
| 12/29/1999 | WO1999066941A1 Herbal extract composition and method with immune-boosting capability |
| 12/29/1999 | WO1999066908A1 Matrix-type transdermal patch for steroid hormones |
| 12/29/1999 | WO1999066906A1 Sticking plaster for controlled release of natural interferon |
| 12/29/1999 | WO1999066902A1 Injectable pharmaceutical formulations of partricin derivatives |
| 12/29/1999 | WO1999066901A2 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 12/29/1999 | WO1999055377A3 Polyol-ifn-beta conjugates |
| 12/29/1999 | WO1999055305A3 Controlled release peroral compositions of levosimendan |
| 12/29/1999 | WO1998055150A8 Txu-7-pap immunotoxin and use thereof |
| 12/29/1999 | EP0967200A1 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations |
| 12/29/1999 | EP0966974A1 Antibacterial composition for topical administration containing antibiotics |
| 12/29/1999 | EP0966973A1 Sorbefacients |
| 12/29/1999 | EP0966972A1 Topical composition containing silicon gum |
| 12/29/1999 | EP0966966A2 Nefazodone dosage form |
| 12/29/1999 | EP0966963A1 Use of indigoid bisindole derivatives as CDK1 inhibitors |
| 12/29/1999 | EP0966959A1 Production of new polymer liquid crystals capable of having an interaction with liposomes |